Dr Rachel Harding

Rachel Harding is an Assistant Professor at the University of Toronto. She holds cross appointments at the Leslie Dan Faculty of Pharmacy, Department of Pharmacology and Toxicology, Structural Genomics Consortium and the Princess Margaret Cancer Centre. Rachel completed her undergraduate and DPhil in structural biology at the University of Oxford, before moving to the University of Toronto for her postdoctoral training. A key focus of Rachel’s research is the huntingtin protein, mutated in people with Huntington’s disease. Rachel studies the 3D shape of the huntingtin protein in both its regular and disease forms, with a view to better understand the drivers of HD, as well as trying to find new avenues of therapeutic intervention.